Alexandra J. Lansky, MD
Research Study Specialist · New Haven, CT
Alexandra J. Lansky, MD is a research study specialist with a practice address in New Haven, Connecticut, and NPI 1336227172, issued on Nov 1, 2006. Check the license (Connecticut 049263, as entered in NPPES) with the Connecticut board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Alexandra J. Lansky
- Credential
- MD
- Primary taxonomy
- Research Study Specialist 1744R1102X
- License numbers
- 049263 CT
216597 NY
Self-reported in NPPES; status is on the state search - Practice location
- 300 George St, New Haven, CT 06511
- Phone
- (203) 737-2142
- Enumerated
- Nov 1, 2006
- Record last updated
- Oct 18, 2010 (not updated in 16 years: call before relying on the address or phone)
- Fax
- (203) 737-6118
- Medicaid ID
- 01820295 NY
- Medicare enrollment
- Enrolled (PECOS I20110201000107); accepts Medicare assignment
- Medical or professional school
- Virginia Commonwealth University, School Of Medicine, 1990
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
5 nearest research study specialist records → All 6 in Connecticut → Look up another NPI →
Also registered at 300 George St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Yasmeen Abdul-KarimPsychiatry Physician1609296292
- Simran Ailani, M.B.B.S.Student in an Organized Health Care Education/Training Program1568107522
- Marissa Bayerl, APRNPsychiatric/Mental Health Nurse Practitioner1972958429
- Hilary Blumberg, M.D.Psychiatry Physician1679511299
- John Cahill, MDPsychiatry Physician1467690271
- Lara Chepenik, M.D. PH.D.Specialist1528265444
Verify Alexandra J. Lansky in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Connecticut board licenses this profession
Search for license 049263Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
51% more Medicare Part D claims than the average research study specialist in 2024
467 Medicare Part D claims for 61 beneficiaries, against an average of 309 among the 12 providers of this specialty who prescribed in Part D. Brand-name drugs were 12% of claims.
Most prescribed
- Atorvastatin Calcium67 claims
- Metoprolol Succinate49 claims
- Losartan Potassium42 claims
- Rosuvastatin Calcium37 claims
- Amlodipine Besylate28 claims
- Clopidogrel25 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 73.6 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $7,818.66
5 payments; by number, the most common kind was honoraria; the largest payer was Abiomed. The 14 providers of this specialty with any payment received $4,217.62 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Yale UniversityNew Haven, CT
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Research Study Specialist providers in Connecticut
There are 6 research study specialist records in Connecticut.
All 6 in Connecticut → Every provider in New Haven → Research Study Specialist nationwide →
The 5 research study specialist records with the nearest ZIP codes
- Chungsoo Kim, PHARMD, PHDNew Haven, CT 065101356202394
- Donald Redmond, M.D.Hamden, CT 065171114392537
- Karen Kumor, M.D.Madison, CT 064431841732245
- Stephen Wardlaw, M.D.Lyme, CT 063711114150679
- Leslie Caromile, PHDFarmington, CT 060301104790708
Common questions
What is Alexandra J. Lansky, MD's NPI number?
Alexandra J. Lansky, MD's National Provider Identifier (NPI) is 1336227172, issued on Nov 1, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Alexandra J. Lansky, MD located?
The NPPES record lists a practice address at 300 George St, New Haven, CT, 06511. Phone: (203) 737-2142. Providers update this record themselves, so call before visiting.
How can I verify Alexandra J. Lansky, MD's license?
NPPES lists Connecticut license number 049263, as entered by the provider. Search the Connecticut board that licenses this profession; the NPPES record confirms identity only.
How much does Alexandra J. Lansky, MD prescribe under Medicare Part D?
In 2024, Alexandra J. Lansky, MD had 467 Medicare Part D claims for 61 beneficiaries; the average among research study specialist prescribers was 309. Part D covers Medicare prescriptions only.
What is Alexandra J. Lansky, MD's MIPS final score?
The 2023 MIPS final score is 73.6 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.